PATENT CLAIM ANALYSIS

Application Number: 16096523
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to a pharmaceutical composition, particularly a modified release tablet composition comprising mirabegron or a pharmaceutically acceptable salt thereof and to a process for preparing such a composition.

Claim (Index 13):
The multilayer tablet according to  claim 11  further comprising solifenacin.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15730988', '10842809', '10843005', '14352785', '13073677']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6758968647458169
- 35 USC 102 Novelty (BERT): 0.4982043926166106
- Combined Prediction Score: 0.6581276175328963
- Mean Citation Score: 213.84979600000003
- Max Citation Score: 266.375
- Similarity Product: 234.3697659373284

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test